image
NextCure, Inc. NXTC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.47
3.84 %
$ 13.2 M
Market Cap
-0.27
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
22.16%
Net Income Estimate
28.85%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets NextCure, Inc.
image
NXTC has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart NXTC

image
$25.0m$25.0m$20.0m$20.0m$15.0m$15.0m$10.0m$10.0m$5.0m$5.0m$0.0$0.0201920192020202020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart NXTC

image
$20.0m$20.0m$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)201920192020202020232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart NXTC

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)201920192020202020232023202420242025202520262026202720272028202820292029